Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Finn

Showing results (281-290 of 410) with videos related to

Pageof 41
Sort By:
ACS Nano|August 14, 2020
Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune ResponsesMohammad Murshid Alam, Cassie M Jarvis, Robert Hincapie, et al.
JACS Au|July 5, 2022
Scalable Formation of Diamine-Appended Metal-Organic Framework Hollow Fiber Sorbents for Postcombustion CO<sub>2</sub> CaptureWenying Quan, Hannah E Holmes, Fengyi Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 31, 2023
Multivalent Targeting of the Asialoglycoprotein Receptor by Virus-Like ParticlesRobert Hincapie, Sonia Bhattacharya, Michael M Baksh, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2010
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicityKatie J Doores, Zara Fulton, Vu Hong, et al.
Virology|September 28, 2005
Systemic trafficking of plant virus nanoparticles in mice via the oral routeChris S Rae, Ing Wei Khor, Qian Wang, et al.
Cancer Cell|January 15, 2016
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid LeukemiaNgai Cheung, Tsz Kan Fung, Bernd B Zeisig, et al.
Biomacromolecules|July 27, 2012
Engineered mutations change the structure and stability of a virus-like particleJason D Fiedler, Cody Higginson, Marisa L Hovlid, et al.
Biomacromolecules|September 27, 2017
Heparin Binding to an Engineered Virus-like Nanoparticle AntagonistHo Yong Cheong, Myles Groner, Kevin Hong, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Glycan-costumed virus-like particles promote type 1 anti-tumor immunityValerie Lensch, Adele Gabba, Robert Hincapie, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Characterization Standard for <i>In-situ</i> Cryo-electron TomographyMallak Ali, Joshua Hutchings, Tahiti Dutta, et al.
Pageof 41

Showing results (281-290 of 410) with videos related to

Sort By:
Pageof 41
ACS Nano|August 14, 2020
Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune ResponsesMohammad Murshid Alam, Cassie M Jarvis, Robert Hincapie, et al.
JACS Au|July 5, 2022
Scalable Formation of Diamine-Appended Metal-Organic Framework Hollow Fiber Sorbents for Postcombustion CO<sub>2</sub> CaptureWenying Quan, Hannah E Holmes, Fengyi Zhang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 31, 2023
Multivalent Targeting of the Asialoglycoprotein Receptor by Virus-Like ParticlesRobert Hincapie, Sonia Bhattacharya, Michael M Baksh, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2010
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicityKatie J Doores, Zara Fulton, Vu Hong, et al.
Virology|September 28, 2005
Systemic trafficking of plant virus nanoparticles in mice via the oral routeChris S Rae, Ing Wei Khor, Qian Wang, et al.
Cancer Cell|January 15, 2016
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid LeukemiaNgai Cheung, Tsz Kan Fung, Bernd B Zeisig, et al.
Biomacromolecules|July 27, 2012
Engineered mutations change the structure and stability of a virus-like particleJason D Fiedler, Cody Higginson, Marisa L Hovlid, et al.
Biomacromolecules|September 27, 2017
Heparin Binding to an Engineered Virus-like Nanoparticle AntagonistHo Yong Cheong, Myles Groner, Kevin Hong, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Glycan-costumed virus-like particles promote type 1 anti-tumor immunityValerie Lensch, Adele Gabba, Robert Hincapie, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Characterization Standard for <i>In-situ</i> Cryo-electron TomographyMallak Ali, Joshua Hutchings, Tahiti Dutta, et al.
Pageof 41